LJ
SSY Group Limited
LJUIF · OTC
$0.40 +0.00% (+$0.00)
Market Cap $9.31B
P/E Ratio 19.80x
Div. Yield 2.53%
ROE 6.36%
Bulios Fair Price
$0.51
26.7% upside
Trenutna cena
$0.4
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LJUIF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
58 /100
Fair P/E 19.80x
P/B 1.28x
EV/EBITDA 13.45x
Growth
5 /100
Declining EPS growth 25.05%
Book val. growth 5.51%
Rev. growth 13.50%
Profitability
57 /100
Moderate Gross margin 38.92%
FCF margin 7.20%
Net margin 11.30%
Quality
23 /100
Poor ROIC 2.91%
Asset turnover 0.33x
ROE 6.36%
Debt
64 /100
Moderate Debt/Equity 0.55x
Net debt/EBITDA 2.61x
Current ratio 1.89x
Stability
75 /100
Stable Beta 0.53x
Profitable years 6
Rev. volatility 14.27%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LJUIF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ji Guang Qu
Employees
5,500
Headquarters
Hong Kong
Prihajajoči dogodki
26 MAR.
Earnings
Upcoming earnings report